Works by Nakamura, Masato


Results: 278
    1

    Relationship Between Platelet Reactivity and Ischemic and Bleeding Events After Percutaneous Coronary Intervention in East Asian Patients: 1-Year Results of the PENDULUM Registry.

    Published in:
    2020
    By:
    • Masato Nakamura;
    • Kazushige Kadota;
    • Akihiko Takahashi;
    • Junji Kanda;
    • Hitoshi Anzai;
    • Yasuhiro Ishii;
    • Yoshisato Shibata;
    • Yoshinori Yasaka;
    • Itaru Takamisawa;
    • Junichi Yamaguchi;
    • Yoshihiro Takeda;
    • Atsushi Harada;
    • Tomoko Motohashi;
    • Raisuke Iijima;
    • Shiro Uemura;
    • Yoshitaka Murakami;
    • Nakamura, Masato;
    • Kadota, Kazushige;
    • Takahashi, Akihiko;
    • Kanda, Junji
    Publication type:
    journal article
    2
    3
    4

    Expression pattern of angiogenic factors and prognosis after hepatic resection in hepatocellular carcinoma: importance of angiopoietin-2 and hypoxia-induced factor-1a.

    Published in:
    Liver International, 2006, v. 26, n. 4, p. 414, doi. 10.1111/j.1478-3231.2006.01243.x
    By:
    • Wada, Hiroshi;
    • Nagano, Hiroaki;
    • Yamamoto, Hirofumi;
    • Yang, Yubo;
    • Kondo, Motoi;
    • Ota, Hideo;
    • Nakamura, Masato;
    • Yoshioka, Shinichi;
    • Kato, Hitoshi;
    • Damdinsuren, Bazarragchaa;
    • Tang, Di;
    • Marubashi, Sigeru;
    • Miyamoto, Atsushi;
    • Takeda, Yutaka;
    • Umeshita, Koji;
    • Nakamori, Shoji;
    • Sakon, Masato;
    • Dono, Keizo;
    • Wakasa, Kenichi;
    • Monden, Morito
    Publication type:
    Article
    5
    6
    7
    8
    9

    Association of the Hemoglobin to Serum Creatinine Ratio with In-Hospital Adverse Outcomes after Percutaneous Coronary Intervention among Non-Dialysis Patients: Insights from a Japanese Nationwide Registry (J-PCI Registry).

    Published in:
    Journal of Clinical Medicine, 2020, v. 9, n. 11, p. 3612, doi. 10.3390/jcm9113612
    By:
    • Numasawa, Yohei;
    • Inohara, Taku;
    • Ishii, Hideki;
    • Yamaji, Kyohei;
    • Kohsaka, Shun;
    • Sawano, Mitsuaki;
    • Kodaira, Masaki;
    • Uemura, Shiro;
    • Kadota, Kazushige;
    • Amano, Tetsuya;
    • Nakamura, Masato;
    • Ikari, Yuji
    Publication type:
    Article
    10
    11

    Phase Ib/II Study of Biweekly TAS‐102 in Combination with Bevacizumab for Patients with Metastatic Colorectal Cancer Refractory to Standard Therapies (BiTS Study).

    Published in:
    Oncologist, 2020, v. 25, n. 12, p. e1855, doi. 10.1634/theoncologist.2020-0643
    By:
    • Satake, Hironaga;
    • Kato, Takeshi;
    • Oba, Koji;
    • Kotaka, Masahito;
    • Kagawa, Yoshinori;
    • Yasui, Hisateru;
    • Nakamura, Masato;
    • Watanabe, Takanori;
    • Matsumoto, Toshihiko;
    • Kii, Takayuki;
    • Terazawa, Tetsuji;
    • Makiyama, Akitaka;
    • Takano, Nao;
    • Yokota, Mitsuru;
    • Okita, Yoshihiro;
    • Matoba, Koreatsu;
    • Hasegawa, Hiroko;
    • Tsuji, Akihito;
    • Komatsu, Yoshito;
    • Yoshino, Takayuki
    Publication type:
    Article
    12

    Comprehensive Analysis of Radiologic Cancer-Free Status through Various Treatment Approaches in Advanced-Stage Hepatocellular Carcinoma.

    Published in:
    Liver Cancer (2235-1795), 2025, v. 14, n. 3, p. 286, doi. 10.1159/000542577
    By:
    • Koroki, Keisuke;
    • Ogasawara, Sadahisa;
    • Izai, Ryo;
    • Yonemoto, Takuya;
    • Akatsuka, Teppei;
    • Miwa, Chihiro;
    • Yumita, Sae;
    • Inoue, Masanori;
    • Kobayashi, Kazufumi;
    • Kiyono, Soichiro;
    • Nakamura, Masato;
    • Kanogawa, Naoya;
    • Kondo, Takayuki;
    • Nakamoto, Shingo;
    • Nakada, Shinichiro;
    • Sakai, Nozomu;
    • Yokoyama, Masayuki;
    • Ohtsuka, Masayuki;
    • Kato, Naoya
    Publication type:
    Article
    13

    Assessment of Macrovascular Invasion in Advanced Hepatocellular Carcinoma: Clinical Implications and Treatment Outcomes with Systemic Therapy.

    Published in:
    Liver Cancer (2235-1795), 2025, v. 14, n. 1, p. 8, doi. 10.1159/000539380
    By:
    • Inoue, Masanori;
    • Ogasawara, Sadahisa;
    • Kobayashi, Kazufumi;
    • Okubo, Tomomi;
    • Itokawa, Norio;
    • Obu, Masamichi;
    • Fujimoto, Kentaro;
    • Unozawa, Hidemi;
    • Yumita, Sae;
    • Fujiwara, Kisako;
    • Nakagawa, Miyuki;
    • Kanzaki, Hiroaki;
    • Koroki, Keisuke;
    • Kiyono, Soichiro;
    • Nakamura, Masato;
    • Kanogawa, Naoya;
    • Kondo, Takayuki;
    • Nakamoto, Shingo;
    • Nagashima, Kengo;
    • Itobayashi, Ei
    Publication type:
    Article
    14

    Evolution of Survival Impact of Molecular Target Agents in Patients with Advanced Hepatocellular Carcinoma.

    Published in:
    Liver Cancer (2235-1795), 2022, v. 11, n. 1, p. 48, doi. 10.1159/000519868
    By:
    • Kobayashi, Kazufumi;
    • Ogasawara, Sadahisa;
    • Takahashi, Aya;
    • Seko, Yuya;
    • Unozawa, Hidemi;
    • Sato, Rui;
    • Watanabe, Shunji;
    • Moriguchi, Michihisa;
    • Morimoto, Naoki;
    • Tsuchiya, Satoshi;
    • Iwai, Kenji;
    • Inoue, Masanori;
    • Ogawa, Keita;
    • Ishino, Takamasa;
    • Iwanaga, Terunao;
    • Sakuma, Takafumi;
    • Fujita, Naoto;
    • Kanzaki, Hiroaki;
    • Koroki, Keisuke;
    • Nakamura, Masato
    Publication type:
    Article
    15

    Analyses of Intermediate-Stage Hepatocellular Carcinoma Patients Receiving Transarterial Chemoembolization prior to Designing Clinical Trials.

    Published in:
    Liver Cancer (2235-1795), 2020, v. 9, n. 5, p. 596, doi. 10.1159/000508809
    By:
    • Koroki, Keisuke;
    • Ogasawara, Sadahisa;
    • Ooka, Yoshihiko;
    • Kanzaki, Hiroaki;
    • Kanayama, Kengo;
    • Maruta, Susumu;
    • Maeda, Takahiro;
    • Yokoyama, Masayuki;
    • Wakamatsu, Toru;
    • Inoue, Masanori;
    • Kobayashi, Kazufumi;
    • Kiyono, Soichiro;
    • Nakamura, Masato;
    • Kanogawa, Naoya;
    • Saito, Tomoko;
    • Kondo, Takayuki;
    • Suzuki, Eiichiro;
    • Nakamoto, Shingo;
    • Yasui, Shin;
    • Tawada, Akinobu
    Publication type:
    Article
    16

    Potential of Lenvatinib for an Expanded Indication from the REFLECT Trial in Patients with Advanced Hepatocellular Carcinoma.

    Published in:
    Liver Cancer (2235-1795), 2020, v. 9, n. 4, p. 382, doi. 10.1159/000507022
    By:
    • Maruta, Susumu;
    • Ogasawara, Sadahisa;
    • Ooka, Yoshihiko;
    • Obu, Masamichi;
    • Inoue, Masanori;
    • Itokawa, Norio;
    • Haga, Yuki;
    • Seki, Atsuyoshi;
    • Okabe, Shinichiro;
    • Azemoto, Ryosaku;
    • Itobayashi, Ei;
    • Atsukawa, Masanori;
    • Sugiura, Nobuyuki;
    • Mizumoto, Hideaki;
    • Koroki, Keisuke;
    • Kanayama, Kengo;
    • Kanzaki, Hiroaki;
    • Kobayashi, Kazufumi;
    • Kiyono, Soichiro;
    • Nakamura, Masato
    Publication type:
    Article
    17
    18

    Modified FOLFOXIRI plus cetuximab versus bevacizumab in RAS wild-type metastatic colorectal cancer: a randomized phase II DEEPER trial.

    Published in:
    Nature Communications, 2024, v. 15, n. 1, p. 1, doi. 10.1038/s41467-024-54460-2
    By:
    • Shiozawa, Manabu;
    • Sunakawa, Yu;
    • Watanabe, Takanori;
    • Ota, Hirofumi;
    • Yasui, Hisateru;
    • Yabuno, Taichi;
    • Tei, Mitsuyoshi;
    • Kochi, Mitsugu;
    • Manaka, Dai;
    • Ohori, Hisatsugu;
    • Yamaguchi, Tatsuro;
    • Sagawa, Tamotsu;
    • Kotaka, Masahito;
    • Kubota, Yutaro;
    • Sekikawa, Takashi;
    • Nakamura, Masato;
    • Takeuchi, Masahiro;
    • Ichikawa, Wataru;
    • Fujii, Masashi;
    • Tsuji, Akihito
    Publication type:
    Article
    19

    Controlling Major Portal Vein Invasion Progression during Lenvatinib Treatment by Carbon-Ion Radiotherapy in Patients with Advanced Hepatocellular Carcinoma.

    Published in:
    Case Reports in Oncology, 2021, v. 14, n. 2, p. 1103, doi. 10.1159/000517440
    By:
    • Yoshida, Ryoi;
    • Koroki, Keisuke;
    • Makishima, Hirokazu;
    • Ogasawara, Sadahisa;
    • Ishino, Takamasa;
    • Ogawa, Keita;
    • Nakagawa, Miyuki;
    • Fujiwara, Kisako;
    • Unozawa, Hidemi;
    • Iwanaga, Terunao;
    • Fujita, Naoto;
    • Sakuma, Takafumi;
    • Kanzaki, Hiroaki;
    • Kobayashi, Kazufumi;
    • Kanogawa, Naoya;
    • Kiyono, Soichiro;
    • Nakamura, Masato;
    • Kondo, Takayuki;
    • Saito, Tomoko;
    • Nakagawa, Ryo
    Publication type:
    Article
    20
    21

    Impact of acute decompensation on the prognosis of patients with hepatocellular carcinoma.

    Published in:
    PLoS ONE, 2022, v. 17, n. 1, p. 1, doi. 10.1371/journal.pone.0261619
    By:
    • Kondo, Takayuki;
    • Koroki, Keisuke;
    • Kanzaki, Hiroaki;
    • Kobayashi, Kazufumi;
    • Kiyono, Soichiro;
    • Nakamura, Masato;
    • Kanogawa, Naoya;
    • Saito, Tomoko;
    • Ogasawara, Sadahisa;
    • Ooka, Yoshihiko;
    • Nakamoto, Shingo;
    • Chiba, Tetsuhiro;
    • Arai, Makoto;
    • Kato, Jun;
    • Kuboki, Satoshi;
    • Ohtsuka, Masayuki;
    • Kato, Naoya
    Publication type:
    Article
    22
    23

    Phase 2 study of irinotecan plus cetuximab rechallenge as third-line treatment in KRAS wild-type metastatic colorectal cancer: JACCRO CC-08.

    Published in:
    2020
    By:
    • Masuishi, Toshiki;
    • Tsuji, Akihito;
    • Kotaka, Masahito;
    • Nakamura, Masato;
    • Kochi, Mitsugu;
    • Takagane, Akinori;
    • Shimada, Ken;
    • Denda, Tadamichi;
    • Segawa, Yoshihiko;
    • Tanioka, Hiroaki;
    • Hara, Hiroki;
    • Sagawa, Tamotsu;
    • Watanabe, Takanori;
    • Takahashi, Takao;
    • Negoro, Yuji;
    • Manaka, Dai;
    • Fujita, Hideto;
    • Suto, Takeshi;
    • Takeuchi, Masahiro;
    • Ichikawa, Wataru
    Publication type:
    journal article
    24
    25

    Catheter-based ultrasound renal denervation in patients with resistant hypertension: the randomized, controlled REQUIRE trial.

    Published in:
    Hypertension Research, 2022, v. 45, n. 2, p. 221, doi. 10.1038/s41440-021-00754-7
    By:
    • Kario, Kazuomi;
    • Yokoi, Yoshiaki;
    • Okamura, Keisuke;
    • Fujihara, Masahiko;
    • Ogoyama, Yukako;
    • Yamamoto, Eiichiro;
    • Urata, Hidenori;
    • Cho, Jin-Man;
    • Kim, Chong-Jin;
    • Choi, Seung-Hyuk;
    • Shinohara, Keisuke;
    • Mukai, Yasushi;
    • Ikemoto, Tomokazu;
    • Nakamura, Masato;
    • Seki, Shuichi;
    • Matoba, Satoaki;
    • Shibata, Yoshisato;
    • Sugawara, Shigeo;
    • Yumoto, Kazuhiko;
    • Tamura, Kouichi
    Publication type:
    Article
    26

    Impact of UGT1A1 genotype on the efficacy and safety of irinotecan-based chemotherapy in metastatic colorectal cancer.

    Published in:
    Cancer Science, 2021, v. 112, n. 11, p. 4669, doi. 10.1111/cas.15092
    By:
    • Satoru Iwasa;
    • Kei Muro;
    • Satoshi Morita;
    • Young Suk Park;
    • Masato Nakamura;
    • Masahito Kotaka;
    • Tomohiro Nishina;
    • Hiroshi Matsuoka;
    • Joong Bae Ahn;
    • Keun-Wook Lee;
    • Yong Sang Hong;
    • Sae Won Han;
    • Sang-Hee Cho;
    • Dong-Sheng Zhang;
    • Wei-Jia Fang;
    • Li Bai;
    • Xiang-Lin Yuan;
    • Ying Yuan;
    • Yasuhide Yamada;
    • Junichi Sakamoto
    Publication type:
    Article
    27

    Advanced colorectal cancer subtypes (aCRCS) help select oxaliplatin‐based or irinotecan‐based therapy for colorectal cancer.

    Published in:
    Cancer Science, 2021, v. 112, n. 4, p. 1567, doi. 10.1111/cas.14841
    By:
    • Takahashi, Shin;
    • Sakamoto, Yasuhiro;
    • Denda, Tadamichi;
    • Takashima, Atsuo;
    • Komatsu, Yoshito;
    • Nakamura, Masato;
    • Ohori, Hisatsugu;
    • Yamaguchi, Tatsuro;
    • Kobayashi, Yoshimitsu;
    • Baba, Hideo;
    • Kotake, Masanori;
    • Amagai, Kenji;
    • Kondo, Hitoshi;
    • Shimada, Ken;
    • Sato, Atsushi;
    • Yuki, Satoshi;
    • Okita, Akira;
    • Ouchi, Kota;
    • Komine, Keigo;
    • Watanabe, Mika
    Publication type:
    Article
    28
    29
    30
    31
    32
    33
    34

    Disagreement between patient‐ and physician‐reported outcomes on symptomatic adverse events as poor prognosis in patients treated with first‐line cetuximab plus chemotherapy for unresectable metastatic colorectal cancer: Results of Phase II QUACK trial

    Published in:
    Cancer Medicine, 2020, v. 9, n. 24, p. 9419, doi. 10.1002/cam4.3564
    By:
    • Ooki, Akira;
    • Morita, Satoshi;
    • Tsuji, Akihito;
    • Iwamoto, Shigeyoshi;
    • Hara, Hiroki;
    • Tanioka, Hiroaki;
    • Satake, Hironaga;
    • Kataoka, Masato;
    • Kotaka, Masahito;
    • Kagawa, Yoshinori;
    • Nakamura, Masato;
    • Shingai, Tatsushi;
    • Ishikawa, Masashi;
    • Miyake, Yasuhiro;
    • Suto, Takeshi;
    • Hashiguchi, Yojiro;
    • Yabuno, Taichi;
    • Ando, Masahiko;
    • Sakamoto, Junichi;
    • Yamaguchi, Kensei
    Publication type:
    Article
    35

    Patient‐reported symptom burden as a prognostic factor in treatment with first‐line cetuximab plus chemotherapy for unresectable metastatic colorectal cancer: Results of Phase II QUACK trial.

    Published in:
    Cancer Medicine, 2020, v. 9, n. 5, p. 1779, doi. 10.1002/cam4.2826
    By:
    • Ooki, Akira;
    • Morita, Satoshi;
    • Iwamoto, Shigeyoshi;
    • Hara, Hiroki;
    • Tanioka, Hiroaki;
    • Satake, Hironaga;
    • Kataoka, Masato;
    • Kotaka, Masahito;
    • Kagawa, Yoshinori;
    • Nakamura, Masato;
    • Shingai, Tatsushi;
    • Ishikawa, Masashi;
    • Miyake, Yasuhiro;
    • Suto, Takeshi;
    • Hashiguchi, Yojiro;
    • Yabuno, Taichi;
    • Sakamoto, Junichi;
    • Tsuji, Akihito;
    • Ando, Masahiko;
    • Yamaguchi, Kensei
    Publication type:
    Article
    36

    A prospective Phase II study to examine the relationship between quality of life and adverse events of first‐line chemotherapy plus cetuximab in patients with KRAS wild‐type unresectable metastatic colorectal cancer: QUACK trial.

    Published in:
    Cancer Medicine, 2018, v. 7, n. 9, p. 4217, doi. 10.1002/cam4.1623
    By:
    • Iwamoto, Shigeyoshi;
    • Ooki, Akira;
    • Morita, Satoshi;
    • Hara, Hiroki;
    • Tanioka, Hiroaki;
    • Satake, Hironaga;
    • Kataoka, Masato;
    • Kotaka, Masahito;
    • Kagawa, Yoshinori;
    • Nakamura, Masato;
    • Shingai, Tatsushi;
    • Ishikawa, Masashi;
    • Miyake, Yasuhiro;
    • Sudo, Takeshi;
    • Hashiguchi, Yojiro;
    • Yabuno, Taichi;
    • Sakamoto, Junichi;
    • Tsuji, Akihito;
    • Ando, Masahiko;
    • Yamaguchi, Kensei
    Publication type:
    Article
    37
    38
    39

    Switching to systemic therapy after locoregional treatment failure: Definition and best timing.

    Published in:
    Clinical & Molecular Hepatology, 2020, v. 26, n. 2, p. 155, doi. 10.3350/cmh.2019.0021n
    By:
    • Sadahisa Ogasawara;
    • Yoshihiko Ooka;
    • Keisuke Koroki;
    • Susumu Maruta;
    • Hiroaki Kanzaki;
    • Kengo Kanayama;
    • Kazufumi Kobayashi;
    • Soichiro Kiyono;
    • Masato Nakamura;
    • Naoya Kanogawa;
    • Tomoko Saito;
    • Takayuki Kondo;
    • Eiichiro Suzuki;
    • Shingo Nakamoto;
    • Akinobu Tawada;
    • Tetsuhiro Chiba;
    • Makoto Arai;
    • Jun Kato;
    • Naoya Kato
    Publication type:
    Article
    40
    41
    42
    43
    44
    45
    46
    47
    48
    49
    50